의료용 개인보호장비(PPE) 시장 규모, 점유율, 성장 및 세계 업계 분석 : 유형 및 용도별, 지역별 인사이트 및 예측(2026-2034년)

Growth Factors of healthcare personal protective equipment (PPE) Market

The global healthcare personal protective equipment (PPE) market has witnessed steady growth, driven by heightened awareness of infection control and worker safety following the COVID-19 pandemic. The market was valued at USD 26.54 billion in 2025 and is projected to reach USD 27.64 billion in 2026, further expanding to USD 34.43 billion by 2034, registering a compound annual growth rate (CAGR) of 2.80% during 2026-2034.

North America dominated the global market in 2025, accounting for 23.30% share, supported by strict safety regulations and strong healthcare infrastructure. The U.S. market is expected to grow significantly, reaching USD 11.79 billion by 2032, driven by regulatory mandates and increased PPE adoption across healthcare facilities.

Market Dynamics

Key Growth Drivers

The primary factor driving market growth is the rising demand for PPE in healthcare settings. Products such as gloves, masks, gowns, face shields, and goggles are essential for preventing infection transmission. The pandemic significantly increased awareness regarding occupational safety, encouraging governments and healthcare institutions to maintain higher PPE stock levels.

Additionally, increasing surgical procedures and chronic disease prevalence have boosted the demand for disposable gloves and protective clothing. Manufacturers are expanding production capacities; for instance, global production of N95 respirators increased significantly during the pandemic to meet rising demand.

Market Restraints

Despite strong demand, the market faces challenges such as skin allergies and injuries caused by prolonged PPE usage. Reports indicate that over 40% of healthcare workers experienced skin damage due to masks, gloves, and protective clothing. Issues like sweating, pressure injuries, and irritation can reduce user compliance and hinder market growth.

Market Trends

Integration of Artificial Intelligence (AI)

A notable trend shaping the PPE market is the integration of artificial intelligence in healthcare systems, particularly in Asia Pacific. AI-powered tools are improving diagnostic efficiency, reducing workload on healthcare workers, and enhancing resource management.

For example, AI platforms developed in collaboration with research institutions can analyze CT scans within seconds, enabling rapid diagnosis during health emergencies. Countries such as China, Malaysia, and the Philippines are actively adopting AI-driven healthcare solutions, indirectly supporting PPE demand by strengthening healthcare infrastructure.

Segmentation Analysis

By Product

The market is segmented into protective clothing, gloves, and eye & face protection.

• Protective clothing dominates the segment due to high demand for isolation gowns and coveralls.
• Gloves are witnessing strong growth due to their critical role in infection prevention.
• Face masks and goggles remain essential for respiratory and eye protection.

By End-user

Based on end-users, the market includes healthcare facilities, consumers, and others.

• Healthcare facilities account for the largest share due to mandatory PPE usage in hospitals and clinics.
• Growing awareness among individuals has also increased PPE adoption among consumers and frontline workers.

Regional Insights

• North America leads the market, supported by regulatory frameworks and advanced healthcare systems.
• Asia Pacific is the fastest-growing region, driven by large-scale production in China and increasing healthcare investments in India.
• Europe shows stable growth due to government initiatives and support from organizations for PPE distribution.

India has significantly boosted domestic PPE production, reducing dependency on imports and strengthening its position in the global supply chain.

Competitive Landscape

The market is highly competitive and fragmented, with key players such as 3M, Honeywell, Ansell, and DuPont leading the industry.

Companies are focusing on strategic partnerships, capacity expansion, and product innovation to strengthen their market presence. Collaborations during the pandemic helped address supply chain disruptions and meet urgent demand for PPE products globally.

Conclusion

The healthcare PPE market is poised for steady and sustained growth through 2034, supported by continuous emphasis on safety, infection control, and healthcare preparedness. While challenges such as skin-related issues and supply chain disruptions persist, advancements in technology and increasing global awareness are expected to offset these limitations.

In the long term, government regulations, domestic manufacturing expansion, and integration of advanced technologies like AI will play a crucial role in shaping the market. As healthcare systems worldwide prioritize preparedness for future health crises, the demand for PPE is expected to remain strong, ensuring consistent market expansion.

Segmentation By Product

• Protective Clothing
  • Coveralls
  • Isolation Gowns
  • Others
• Eye & Face Protection
  • Face Mask
• N95 Respirators
• Surgical Masks & Others
  • Safety Goggles
  • Others
• Gloves
  • Examination
  • Surgical

By End-user

• Healthcare Facilities
• Consumers
• Others

By Region

• North America (By Product, End-user, Country)
  • U.S. (By End-user)
  • Canada (By End-user)
• Europe (By Product, End-user, Country)
  • Germany (By End-user)
  • U.K. (By End-user)
  • France (By End-user)
  • Italy (By End-user)
  • Spain (By End-user)
  • Rest of Europe (By End-user)
• Asia Pacific (By Product, End-user, Country)
  • China (By End-user)
  • Japan (By End-user)
  • India (By End-user)
  • South Korea (By End-user)
  • Southeast Asia (By End-user)
  • Rest of Asia Pacific (By End-user)
• Latin America (By Product, End-user, Country)
  • Brazil (By End-user)
  • Mexico (By End-user)
  • Rest of Latin America (By End-user)
• Middle East & Africa (By Product, End-user, Country)
  • South Africa (By End-user)
  • Saudi Arabia (By End-user)
  • Rest of Middle East & Africa (By End-user)

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Emerging Trends

4. Key Insights

• 4.1. Key Emerging Trends - For Major Countries
• 4.2. Regulatory Analysis
• 4.3. Latest Technological Advancements
• 4.4. Porter's Five Forces Analysis
• 4.5. Recent Industry Developments - Policies, Partnerships, New Product Launches, and Mergers & Acquisitions
• 4.6. Impact of COVID-19 on Global Healthcare Personal Protective Equipment (PPE) Market

5. Global Healthcare Personal Protective Equipment (PPE) Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Key Findings / Summary
• 5.2. By Product (Value)
  • 5.2.1. Protective Clothing
    • 5.2.1.1. Coveralls
    • 5.2.1.2. Isolation Gowns
    • 5.2.1.3. Others
  • 5.2.2. Eye & Face Protection
    • 5.2.2.1. Face Mask
      • 5.2.2.1.1. N95 Respirators
      • 5.2.2.1.2. Surgical Masks & Others
    • 5.2.2.2. Safety Goggles
    • 5.2.2.3. Others
  • 5.2.3. Gloves
    • 5.2.3.1. Examination
    • 5.2.3.2. Surgical
• 5.3. By End-user (Value)
  • 5.3.1. Healthcare Facilities
  • 5.3.2. Consumers
  • 5.3.3. Others
• 5.4. By Region (Value)
  • 5.4.1. North America
  • 5.4.2. Europe
  • 5.4.3. Asia Pacific
  • 5.4.4. Latin America
  • 5.4.5. Middle East & Africa

6. North America Healthcare Personal Protective Equipment (PPE) Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Key Findings / Summary
• 6.2. By Product (Value)
  • 6.2.1. Protective Clothing
    • 6.2.1.1. Coveralls
    • 6.2.1.2. Isolation Gowns
    • 6.2.1.3. Others
  • 6.2.2. Eye & Face Protection
    • 6.2.2.1. Face Mask
      • 6.2.2.1.1. N95 Respirators
      • 6.2.2.1.2. Surgical Masks & Others
    • 6.2.2.2. Safety Goggles
    • 6.2.2.3. Others
  • 6.2.3. Gloves
    • 6.2.3.1. Examination
    • 6.2.3.2. Surgical
• 6.3. By End-user (Value)
  • 6.3.1. Healthcare Facilities
  • 6.3.2. Consumers
  • 6.3.3. Others
• 6.4. By Country (Value)
  • 6.4.1. U.S.
    • 6.4.1.1. By End-user (Value)
      • 6.4.1.1.1. Healthcare Facilities
      • 6.4.1.1.2. Consumers
      • 6.4.1.1.3. Others
  • 6.4.2. Canada
    • 6.4.2.1. By End-user (Value)
      • 6.4.2.1.1. Healthcare Facilities
      • 6.4.2.1.2. Consumers
      • 6.4.2.1.3. Others

7. Europe Healthcare Personal Protective Equipment (PPE) Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Key Findings / Summary
• 7.2. By Product (Value)
  • 7.2.1. Protective Clothing
    • 7.2.1.1. Coveralls
    • 7.2.1.2. Isolation Gowns
    • 7.2.1.3. Others
  • 7.2.2. Eye & Face Protection
    • 7.2.2.1. Face Mask
      • 7.2.2.1.1. N95 Respirators
      • 7.2.2.1.2. Surgical Masks & Others
    • 7.2.2.2. Safety Goggles
    • 7.2.2.3. Others
  • 7.2.3. Gloves
    • 7.2.3.1. Examination
    • 7.2.3.2. Surgical
• 7.3. By End-user (Value)
  • 7.3.1. Healthcare Facilities
  • 7.3.2. Consumers
  • 7.3.3. Others
• 7.4. By Country (Value)
  • 7.4.1. Germany
    • 7.4.1.1. By End-user (Value)
      • 7.4.1.1.1. Healthcare Facilities
      • 7.4.1.1.2. Consumers
      • 7.4.1.1.3. Others
  • 7.4.2. U.K.
    • 7.4.2.1. By End-user (Value)
      • 7.4.2.1.1. Healthcare Facilities
      • 7.4.2.1.2. Consumers
      • 7.4.2.1.3. Others
  • 7.4.3. France
    • 7.4.3.1. By End-user (Value)
      • 7.4.3.1.1. Healthcare Facilities
      • 7.4.3.1.2. Consumers
      • 7.4.3.1.3. Others
  • 7.4.4. Italy
    • 7.4.4.1. By End-user (Value)
      • 7.4.4.1.1. Healthcare Facilities
      • 7.4.4.1.2. Consumers
      • 7.4.4.1.3. Others
  • 7.4.5. Spain
    • 7.4.5.1. By End-user (Value)
      • 7.4.5.1.1. Healthcare Facilities
      • 7.4.5.1.2. Consumers
      • 7.4.5.1.3. Others
  • 7.4.6. Rest of Europe
    • 7.4.6.1. By End-user (Value)
      • 7.4.6.1.1. Healthcare Facilities
      • 7.4.6.1.2. Consumers
      • 7.4.6.1.3. Others

8. Asia-Pacific Healthcare Personal Protective Equipment (PPE) Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Key Findings / Summary
• 8.2. By Product (Value)
  • 8.2.1. Protective Clothing
    • 8.2.1.1. Coveralls
    • 8.2.1.2. Isolation Gowns
    • 8.2.1.3. Others
  • 8.2.2. Eye & Face Protection
    • 8.2.2.1. Face Mask
      • 8.2.2.1.1. N95 Respirators
      • 8.2.2.1.2. Surgical Masks & Others
    • 8.2.2.2. Safety Goggles
    • 8.2.2.3. Others
  • 8.2.3. Gloves
    • 8.2.3.1. Examination
    • 8.2.3.2. Surgical
• 8.3. By End-user (Value)
  • 8.3.1. Healthcare Facilities
  • 8.3.2. Consumers
  • 8.3.3. Others
• 8.4. By Country (Value)
  • 8.4.1. China
    • 8.4.1.1. By End-user (Value)
      • 8.4.1.1.1. Healthcare Facilities
      • 8.4.1.1.2. Consumers
      • 8.4.1.1.3. Others
  • 8.4.2. Japan
    • 8.4.2.1. By End-user (Value)
      • 8.4.2.1.1. Healthcare Facilities
      • 8.4.2.1.2. Consumers
      • 8.4.2.1.3. Others
  • 8.4.3. India
    • 8.4.3.1. By End-user (Value)
      • 8.4.3.1.1. Healthcare Facilities
      • 8.4.3.1.2. Consumers
      • 8.4.3.1.3. Others
  • 8.4.4. South Korea
    • 8.4.4.1. By End-user (Value)
      • 8.4.4.1.1. Healthcare Facilities
      • 8.4.4.1.2. Consumers
      • 8.4.4.1.3. Others
  • 8.4.5. Southeast Asia
    • 8.4.5.1. By End-user (Value)
      • 8.4.5.1.1. Healthcare Facilities
      • 8.4.5.1.2. Consumers
      • 8.4.5.1.3. Others
  • 8.4.6. Rest of Asia Pacific
    • 8.4.6.1. By End-user (Value)
      • 8.4.6.1.1. Healthcare Facilities
      • 8.4.6.1.2. Consumers
      • 8.4.6.1.3. Others

9. Latin America Healthcare Personal Protective Equipment (PPE) Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Key Findings / Summary
• 9.2. By Product (Value)
  • 9.2.1. Protective Clothing
    • 9.2.1.1. Coveralls
    • 9.2.1.2. Isolation Gowns
    • 9.2.1.3. Others
  • 9.2.2. Eye & Face Protection
    • 9.2.2.1. Face Mask
      • 9.2.2.1.1. N95 Respirators
      • 9.2.2.1.2. Surgical Masks & Others
    • 9.2.2.2. Safety Goggles
    • 9.2.2.3. Others
  • 9.2.3. Gloves
    • 9.2.3.1. Examination
    • 9.2.3.2. Surgical
• 9.3. By End-user (Value)
  • 9.3.1. Healthcare Facilities
  • 9.3.2. Consumers
  • 9.3.3. Others
• 9.4. By Country (Value)
  • 9.4.1. Brazil
    • 9.4.1.1. By End-user (Value)
      • 9.4.1.1.1. Healthcare Facilities
      • 9.4.1.1.2. Consumers
      • 9.4.1.1.3. Others
  • 9.4.2. Mexico
    • 9.4.2.1. By End-user (Value)
      • 9.4.2.1.1. Healthcare Facilities
      • 9.4.2.1.2. Consumers
      • 9.4.2.1.3. Others
  • 9.4.3. Rest of Latin America
    • 9.4.3.1. By End-user (Value)
      • 9.4.3.1.1. Healthcare Facilities
      • 9.4.3.1.2. Consumers
      • 9.4.3.1.3. Others

10. Middle East & Africa Healthcare Personal Protective Equipment (PPE) Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Key Findings / Summary
• 10.2. By Product (Value)
  • 10.2.1. Protective Clothing
    • 10.2.1.1. Coveralls
    • 10.2.1.2. Isolation Gowns
    • 10.2.1.3. Others
  • 10.2.2. Eye & Face Protection
    • 10.2.2.1. Face Mask
      • 10.2.2.1.1. N95 Respirators
      • 10.2.2.1.2. Surgical Masks & Others
    • 10.2.2.2. Safety Goggles
    • 10.2.2.3. Others
  • 10.2.3. Gloves
    • 10.2.3.1. Examination
    • 10.2.3.2. Surgical
• 10.3. By End-user (Value)
  • 10.3.1. Healthcare Facilities
  • 10.3.2. Consumers
  • 10.3.3. Others
• 10.4. By Country (Value)
  • 10.4.1. South Africa
    • 10.4.1.1. By End-user (Value)
      • 10.4.1.1.1. Healthcare Facilities
      • 10.4.1.1.2. Consumers
      • 10.4.1.1.3. Others
  • 10.4.2. Saudi Arabia
    • 10.4.2.1. By End-user (Value)
      • 10.4.2.1.1. Healthcare Facilities
      • 10.4.2.1.2. Consumers
      • 10.4.2.1.3. Others
  • 10.4.3. Rest of Middle East & Africa
    • 10.4.3.1. By End-user (Value)
      • 10.4.3.1.1. Healthcare Facilities
      • 10.4.3.1.2. Consumers
      • 10.4.3.1.3. Others

11. Competitive Landscape

• 11.1. Global Healthcare Personal Protective Equipment (PPE) Market Revenue Share/Ranking Analysis, By Key Manufacturer
• 11.2. Company Profiles
  • 11.2.1. Honeywell International Inc.
    • 11.2.1.1. Overview
    • 11.2.1.2. Description
    • 11.2.1.3. Product Portfolio
    • 11.2.1.4. Financials (As per Availaibity)
    • 11.2.1.5. Recent Developments
  • 11.2.2. 3M
    • 11.2.2.1. Overview
    • 11.2.2.2. Description
    • 11.2.2.3. Product Portfolio
    • 11.2.2.4. Financials (As per Availaibity)
    • 11.2.2.5. Recent Developments
  • 11.2.3. ANSELL LTD.
    • 11.2.3.1. Overview
    • 11.2.3.2. Description
    • 11.2.3.3. Product Portfolio
    • 11.2.3.4. Financials (As per Availaibity)
    • 11.2.3.5. Recent Developments
  • 11.2.4. Alpha ProTech
    • 11.2.4.1. Overview
    • 11.2.4.2. Description
    • 11.2.4.3. Product Portfolio
    • 11.2.4.4. Financials (As per Availaibity)
    • 11.2.4.5. Recent Developments
  • 11.2.5. Superior Gloves
    • 11.2.5.1. Overview
    • 11.2.5.2. Description
    • 11.2.5.3. Product Portfolio
    • 11.2.5.4. Financials (As per Availaibity)
    • 11.2.5.5. Recent Developments
  • 11.2.6. Medline Industries, Inc.
    • 11.2.6.1. Overview
    • 11.2.6.2. Description
    • 11.2.6.3. Product Portfolio
    • 11.2.6.4. Financials (As per Availaibity)
    • 11.2.6.5. Recent Developments
  • 11.2.7. Cardinal Health
    • 11.2.7.1. Overview
    • 11.2.7.2. Description
    • 11.2.7.3. Product Portfolio
    • 11.2.7.4. Financials (As per Availaibity)
    • 11.2.7.5. Recent Developments
  • 11.2.8. DuPont
    • 11.2.8.1. Overview
    • 11.2.8.2. Description
    • 11.2.8.3. Product Portfolio
    • 11.2.8.4. Financials (As per Availaibity)
    • 11.2.8.5. Recent Developments
  • 11.2.9. Kimberly-Clark Corporation
    • 11.2.9.1. Overview
    • 11.2.9.2. Description
    • 11.2.9.3. Product Portfolio
    • 11.2.9.4. Financials (As per Availaibity)
    • 11.2.9.5. Recent Developments
  • 11.2.10. Sterimed Group
    • 11.2.10.1. Overview
    • 11.2.10.2. Description
    • 11.2.10.3. Product Portfolio
    • 11.2.10.4. Financials (As per Availaibity)
    • 11.2.10.5. Recent Developments
  • 11.2.11. Medisca Inc
    • 11.2.11.1. Overview
    • 11.2.11.2. Description
    • 11.2.11.3. Product Portfolio
    • 11.2.11.4. Financials (As per Availaibity)
    • 11.2.11.5. Recent Developments
  • 11.2.12. Moldex-Metric
    • 11.2.12.1. Overview
    • 11.2.12.2. Description
    • 11.2.12.3. Product Portfolio
    • 11.2.12.4. Financials (As per Availaibity)
    • 11.2.12.5. Recent Developments

12. Strategic Recommendations